ALT: Altimmune, Inc. Stock

by  •  • Comments Off on ALT: Altimmune, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 447.45
Enterprise Value ($M) 410.52
Book Value ($M) 123.51
Book Value / Share 1.60
Price / Book 3.62
NCAV ($M) 121.46
NCAV / Share 1.58
Price / NCAV 3.68

Profitability (mra)
Return on Invested Capital (ROIC) -0.76
Return on Assets (ROA) -0.45
Return on Equity (ROE) -0.49

Liquidity (mrq)
Quick Ratio 13.11
Current Ratio 13.11

Balance Sheet (mrq) ($M)
Current Assets 137.25
Assets 139.31
Liabilities 15.80
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.02
Operating Income -103.17
Net Income -95.06
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -79.85
Cash from Investing -28.39
Cash from Financing 10.04

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-14 13G/A Ameriprise Financial Inc 7.40 35.57
02-05 13G/A BlackRock, Inc. 8.70 52.28
10-17 13G/A State Street Corp 4.80 -12.67
10-16 13G/A Millennium Management Llc 0.20 -95.05

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-02-27 10-K 2024 10-K
2024-11-12 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-08-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-05-09 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-03-27 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-03-21 299,223 1,440,150 20.78
2025-03-20 432,245 1,568,007 27.57
2025-03-19 458,258 1,584,874 28.91
2025-03-18 687,885 2,306,604 29.82
2025-03-17 1,914,597 5,387,340 35.54

(click for more detail)

Similar Companies
ACRV – Acrivon Therapeutics, Inc. ADMA – ADMA Biologics, Inc.
AFMD – Affimed N.V. ANIP – ANI Pharmaceuticals, Inc.
APGE – Apogee Therapeutics, Inc.


Financial data and stock pages provided by
Fintel.io